Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
International Journal of Cancer|June 17, 1998
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptideM Reddish, G D MacLean, R R Koganty, et al.The International Journal of Biological Markers|April 1, 1991
Clinical evaluation of a new two-site assay for CA125 antigenV Capstick, G D Maclean, M R Suresh, et al.British Journal of Cancer|October 1, 1996
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerD W Miles, K E Towlson, R Graham, et al.Cancer Letters|November 1, 1984
Radiolabelled peanut lectin for the scintigraphic detection of cancerS Holt, A Wilkinson, M R Suresh, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1986
Renal tubular receptor imaging with iodine-131-labeled peanut lectin: pharmacokinetics and renal clearance mechanism in animalsG R Boniface, M R Suresh, D J Willans, et al.Advances in Experimental Medicine and Biology|January 1, 1977
Role of the major histocompatibility complex in resistance to Marek's disease: restriction of the growth of JMV-MD tumor cells in genetically resistant birdsB M Longenecker, F Pazderka, J S Gavora, et al.Cancer Research|December 16, 1998
MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeatsJ L Kam, L H Regimbald, J H Hilgers, et al.Hybridoma|December 1, 1996
Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigensK P O'Boyle, A L Markowitz, M Khorshidi, et al.Cell Regulation|May 1, 1991
Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1D B Taichman, M I Cybulsky, I Djaffar, et al.International Journal of Cancer|February 14, 1998
Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccineJ Samuel, W A Budzynski, M A Reddish, et al.Pageof 12